Supply of Interferon Beta-1a (Avonex®)
A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 3 year
- Value
- £7M-£9M
- Sector
- HEALTH
- Published
- 21 Jan 2022
- Delivery
- 01 Dec 2018 to 28 Feb 2022
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated JointBoards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Biogen Idec Maidenhead
Description
This procurement is for the supply of Interferon Beta-1a (Avonex®) to NHSScotland.
Ammendments to Previous Notice
2. Contract value
GBP 7,930,540 8,921,858
Award Detail
| 1 | Biogen Idec (Maidenhead)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
This modification of contract term from 01/03/2022 to [insert date] is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015
Other Information
The total value in Section II.1.7 and V.2.4 refers to the full 39-month duration of the framework agreement. (SC Ref:679436)
Reference
- OJEU 036897-2022